Primary Site >> Colorectal Cancer

Gene >> IGF2BP3

Journal: Clin Cancer Res. 2003 Nov 1;9(14):5120-6.
Title: Recursive partitioning as an approach to selection of immune markers for tumor diagnosis.
Author: Koziol, James A|Zhang, Jian-Ying|Casiano, Carlos A|Peng, Xuan-Xian|Shi, Fu-Dong|Feng, Anne C|Chan, Edward K L|Tan, Eng M
PMID: 14613989
Journal: Scand J Immunol. 2009 Jan;69(1):57-63.
Title: Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.
Author: Liu, W|Wang, P|Li, Z|Xu, W|Dai, L|Wang, K|Zhang, J
PMID: 19140877
Journal: Ann Surg Oncol. 2009 Dec;16(12):3499-506.
Title: IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
Author: Li, Dawei|Yan, Dongwang|Tang, Huamei|Zhou, Chongzhi|Fan, Junwei|Li, Shuxia|Wang, Xiaoliang|Xia, Jun|Huang, Fei|Qiu, Guoqiang|Peng, Zhihai
PMID: 19672661
Journal: Tokai J Exp Clin Med. 2012 Jul 20;37(2):57-61.
Title: Significant clinical response of advanced colon cancer to peptide vaccine therapy: a case report.
Author: Yasuda, Seiei|Tsuchiya, Izumi|Okada, Kazutake|Tanaka, Akira|Suzuki, Toshiyuki|Sadahiro, Sotaro|Takeda, Kazuyoshi|Yamamoto, Soichiro|Nakui, Minoru
PMID: 22763829
Journal: Eur J Cancer. 2012 Dec;48(18):3405-13.
Title: Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.
Author: Lochhead, Paul|Imamura, Yu|Morikawa, Teppei|Kuchiba, Aya|Yamauchi, Mai|Liao, Xiaoyun|Qian, Zhi Rong|Nishihara, Reiko|Wu, Kana|Meyerhardt, Jeffrey A|Fuchs, Charles S|Ogino, Shuji
PMID: 22840368
Journal: Oncol Lett. 2013 Sep;6(3):740-744.
Title: Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma.
Author: Lin, Lijuan|Zhang, Jinhui|Wang, Yan|Ju, Weiei|Ma, Yibing|Li, Lina|Chen, Litian
PMID: 24137402
Journal: PLoS One. 2013 Oct 30;8(10):e76251.
Title: Novel genes associated with colorectal cancer are revealed by high resolution cytogenetic analysis in a patient specific manner.
Author: Eldai, Hisham|Periyasamy, Sathish|Al Qarni, Saeed|Al Rodayyan, Maha|Muhammed Mustafa, Sabeena|Deeb, Ahmad|Al Sheikh, Ebthehal|Afzal, Mohammed|Johani, Mishal|Yousef, Zeyad|Aziz, Mohammad Azhar
PMID: 24204606
Journal: J Transl Med. 2014 Mar 10;12:63.
Title: A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome.
Author: Hazama, Shoichi|Nakamura, Yusuke|Takenouchi, Hiroko|Suzuki, Nobuaki|Tsunedomi, Ryouichi|Inoue, Yuka|Tokuhisa, Yoshihiro|Iizuka, Norio|Yoshino, Shigefumi|Takeda, Kazuyoshi|Shinozaki, Hirokazu|Kamiya, Akira|Furukawa, Hiroyuki|Oka, Masaaki
PMID: 24612787
Journal: Oncoscience. 2015 Jul 1;2(6):607-14.
Title: Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.
Author: Shantha Kumara, Hmc|Kirchoff, Daniel|Caballero, Otavia L|Su, Tao|Ahmed, Aqeel|Herath, Sonali Ac|Njoh, Linda|Cekic, Vesna|Simpson, Andrew J|Cordon-Cardo, Carlos|Whelan, Richard L
PMID: 26244168
Journal: J Gastroenterol. 2016 Oct;51(10):971-84.
Title: Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications.
Author: Belharazem, Djeda|Magdeburg, Julia|Berton, Ann-Kristin|Beissbarth, Li|Sauer, Christian|Sticht, Carsten|Marx, Alexander|Hofheinz, Ralf|Post, Stefan|Kienle, Peter|Strobel, Philipp
PMID: 26984550
Journal: Clin Immunol. 2016 May;166-167:48-58.
Title: Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors.
Author: Murahashi, Mutsunori|Hijikata, Yasuki|Yamada, Kazunari|Tanaka, Yoshihiro|Kishimoto, Junji|Inoue, Hiroyuki|Marumoto, Tomotoshi|Takahashi, Atsushi|Okazaki, Toshihiko|Takeda, Kazuyoshi|Hirakawa, Masakazu|Fujii, Hiroshi|Okano, Shinji|Morita, Masaru|Baba, Eish
PMID: 27072896
Journal: Onco Targets Ther. 2017 Jun 6;10:2849-2863.
Title: Prognostic value of high IMP3 expression in solid tumors: a meta-analysis.
Author: Chen, Luyao|Xie, Yongpeng|Li, Xintao|Gu, Liangyou|Gao, Yu|Tang, Lu|Chen, Jianwen|Zhang, Xu
PMID: 28652767
Journal: Oncol Lett. 2017 Dec;14(6):7304-7310.
Title: Analysis of IMP3 expression in primary tumor and stromal cells in patients with colorectal cancer.
Author: Huang, Xiaoping|Wei, Qingzhu|Liu, Jianghuan|Niu, Hongling|Xiao, Gang|Liu, Lixin
PMID: 29344167
Journal: Mol Med Rep. 2018 Jan;17(1):1065-1070.
Title: Epithelialmesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3.
Author: You, Shuping|Guan, Yun|Li, Weihong
PMID: 29115492
Journal: Biochem Biophys Res Commun. 2018 Sep 10;503(3):1570-1574.
Title: CircRNA circHIPK3 serves as a prognostic marker to promote glioma progression by regulating miR-654/IGF2BP3 signaling.
Author: Jin, Pengcheng|Huang, Yuenuo|Zhu, Penglei|Zou, Yi|Shao, Tingting|Wang, Ouyang
PMID: 30057315